Associate Professor Chris Reid
BPharm, BSci (Hons), PhD

A/Prof Chris Reid is a Principal Research Fellow, member of Faculty and Head of the Neurophysiology of Excitable Networks Laboratory at the Florey Institute of Neuroscience and Mental Health (Florey Institute). He is a translational neuroscientist and leads a multi-disciplinary team investigates the molecular and cellular causes of epilepsy.

His team includes 4 postdoctoral scientists, 2 research assistants, 2 PhD students and 3 honours students. Seminal work has included the development and characterisation of new genetic rodent models of epilepsy and the identification of new molecular targets for treating this devastating disease. This includes roles of ‘pacemaker’ hyperpolarization-activated cyclic nucleotide–gated (HCN) channels in seizure susceptibility.

A/Prof Reid has strong engagement with industry and clinical partners providing a translational path. This includes collaborating with the BioCurate and CSL. He also contributes significantly to the neuroscience community acting as Director of the Australian Course in Advanced Neuroscience (from 2020) and sitting on International League Against Epilepsy (ILAE) and American Epilepsy Society (AES) Genetic Task Forces.

His vision is to continue to drive pre-clinical programs that will create and validate therapeutic strategies targeted at ion channels in epilepsy and other neurological disorders.

Key collaborators:

Maria Novella Romanelli; Professor of Medicinal Chemistry; University of Florence

James Trimmer UC Davis; USA

Samuel Berkovic; Melbourne University

Listen to the NEW TARGETS FOR EPILEPSY TREATMENT PODCAST and hear how Associate Professor Reid is developing new drugs for epilepsy, focussing on both genetics and small molecules, to treat more people with epilepsy

Watch him working to develop new therapeutics for epilepsy here

  • Location

    Florey Institute of Neuroscience and Mental Health
    30 Royal Parade


Awards and achievements

Current grants:

  • Program Grant (2016-20) Human Epilepsy: Understanding biology to improve outcomes ($16 000 000)
  • Project Grant: HCN channels: a novel antiepileptic target ($570 000) 


PhD (Neuroscience, ANU)

BSci (Honours, ANU)

BPharm (Tasmania University)

Research Papers

Showing 10 of 79. VIEW ALL

Showing 10 of 79. VIEW ALL

Support us

Brain health affects all Australians.
You can support our research by making a donation or a bequest.


Latest breakthroughs, news, events & more.